Migrevention

What Migrevention does

Migrevention OÜ is an Estonian deep-tech digital health company founded in 2020 in Tallinn that builds a Digital Headache Clinic platform aimed at headache and migraine patients, neurologists, headache nurses, and healthcare provider organizations. Its core offering consists of two interconnected products: the Headache App, a free iOS/Android patient diary that is classified as a Class I CE-marked medical device and captures structured headache episodes (start time, pain level, location, symptoms, medications) in under 60 seconds including a real-time attack timer and a medication overuse early-warning algorithm; and Patient Manager, a browser-based specialist dashboard providing real-time diary data, episode frequency and treatment trend charts, asynchronous messaging, and automated alert management. Both products are built on the International Headache Standard and a multidisciplinary headache treatment approach, and have been validated in clinical settings to deliver a reported 10x patient-throughput increase per specialist and a 38% reduction in headache visits in primary care.

The company operates a hybrid go-to-market: a freemium product-led motion via the free Headache App drives patient acquisition and top-of-funnel awareness, while an enterprise sales motion targets NHS trusts, private neurology clinics, and research institutions for paid specialist dashboard and remote-monitoring deployments. Migrevention has named partners including Tartu University Hospital and Viljandi Hospital in Estonia and has stated a UK NHS market expansion goal of 25% of relevant NHS hospitals and clinics by 2029. To date, funding has been exclusively non-dilutive, sourced from Norway Grants, the European Regional Development Fund, the Estonian Business and Innovation Agency (EAS), and the EIS Applied Research Programme, across seven disclosed tranches totaling approximately 1.32M EUR. Revenue is not publicly disclosed and the company is best characterized as pre-commercial, with active pilots underway and a UK full-scale launch targeted for 2025. The team is small (~12 members), led by co-founders with deep clinical credentials, and is currently expanding its product surface into a Digital Chronic Pain Clinic MVP under a multi-year grant running through January 2027.

Name

Migrevention

Legal name

Migrevention OÜ

Website

https://migrevention.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Digital Health / Migraine Digital Therapeutics

NAICS

Computer Systems Design Services (541512), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Headache & Migraine Medicine (HLAKAIAE)

akta.pro secondary industry

Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)

Keywords

• Digital headache clinic
• Migraine digital therapeutic
• Patient headache diary
• Remote patient monitoring
• Clinical workflow software

Headquarters

HQ city

Tallinn

HQ country

Estonia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Digital Headache Clinic SaaS: Fully digital headache clinic — patient mobile application and specialist dashboard connected to each other. Revenue likely generated through clinic/hospital subscriptions for the specialist dashboard and remote monitoring services.
2. Headache App (Free): Free clinically validated headache diary available to patients on iOS and Android. Serves as lead generation and product-led growth driver for the paid clinic solution.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Migrevention sells a Digital Headache Clinic platform composed of a free CE-marked Class I medical device patient mobile diary app (Headache App) and a browser-based specialist dashboard (Patient Manager) that connect into one clinical workflow for tracking, treating, and managing headache and migraine. The Headache App captures structured ICHD-3-aligned headache episodes, medication use, and triggers at the point of experience; the Patient Manager surfaces real-time trends, asynchronous messaging, automated alerts, and monthly clinical reports for neurologists, nurses, and headache clinics.

Product overview

Migrevention offers a unified digital headache clinic platform consisting of two interconnected products: the Headache App (a free, clinically validated mobile headache diary for patients on iOS and Android) and the Patient Manager (a browser-based specialist dashboard for clinical teams). The platform enables real-time headache tracking, medication logging, pattern recognition, and structured reporting directly into clinical workflows. The Headache App functions as a Class I medical device (CE marked) and can be used as a standalone free tool or connected to the specialist dashboard for integrated digital care pathways.

Differentiator

Problem solved

Functional benefit

Brands

• Headache App: A free, clinically validated headache diary that helps patients record headache episodes quickly, spot patterns and prepare for appointments with clear data. Available as iOS and Android mobile application.
• Patient Manager

Products and services

• Headache App A free, clinically validated headache diary mobile application for iOS and Android that helps patients with headaches or migraines record episodes in under 60 seconds, spot patterns, track medication use, identify triggers, and prepare for appointments with clear data. It is certified as a Class I medical device (CE-marked) and is built on the International Headache Standard, with a built-in medication overuse early-warning algorithm.
• Patient Manager A browser-based specialist dashboard that brings the full patient picture into the clinical workflow without installation, providing neurologists, nurses, and headache clinics with real-time diary data across their patient panel, episode frequency, medication and treatment trend charts, asynchronous messaging, automated alert management, and structured monthly clinical reports.
• Digital Headache Clinic A fully digital and cost-effective headache clinic solution comprising the Headache App patient mobile application and the Patient Manager specialist dashboard connected to each other, sold to healthcare providers and based on the International Headache Standard and a multidisciplinary headache treatment approach to enable remote patient monitoring and asynchronous specialist headache care.

Quantifiable outcome

• 10x Patient throughput increase per specialist
• +4 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• SA Viljandi Haigla (Viljandi Hospital)coreStrategic or Co-development Partner · 1 August 2024Estonian hospital and clinical innovation partner contributing expertise in chronic pain care, rehabilitation and digitally enabled care models. Partner in Digital Chronic Pain Clinic MVP development project.
• SA Tartu Ülikooli Kliinikum (Tartu University Hospital)coreStrategic or Co-development Partner · 1 January 2024Estonia's largest university hospital and clinical research partner. Contributing expertise in pain management, rehabilitation, and digital health validation. Partner in Digital Chronic Pain Clinic MVP development project and eHL-Migrevention interface creation.
• Quretec OÜcoreTechnology or Integration · 1 January 2020Software development partner established in 2006, specializing in data management solutions, bioinformatics and biostatistics. Provided innovative software development and data management services for the Digital Headache Clinic development. Lead technology partner in joint development projects.
• Connected Health ClustercoreStrategic or Co-development PartnerEstonian digital health cluster with three operational objectives: increasing global visibility and international sales through coordinated joint development, contributing to scalable value-based products/services, and cultivating management and sales ability of health entrepreneurs. Migrevention was lead partner in three joint development projects within this cluster.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Migraine Buddy: One of the most widely used consumer headache and migraine tracking apps globally. Directly comparable as a patient-facing headache diary with structured episode logging, trigger analysis, and pattern recognition, though it is primarily a consumer tool without Migrevention's specialist dashboard or CE-marked SaMD positioning.
• Curelator: Digital migraine and headache platform focused on identifying personal triggers and treatment response. Comparable as a data-driven, condition-specific digital therapeutic for headache, addressing the same patient–clinician information gap that Migrevention's digital clinic targets.
• Kaia Health: Digital therapeutics company for chronic pain (MSK and COPD) with employer and payer channels. Directly comparable as a digital chronic-pain clinic and a leading reference point for Migrevention's planned Digital Chronic Pain Clinic MVP, including similar claims around reducing in-person visits.

Emerging players

• Bearable: Consumer health tracking app covering mood, symptoms, sleep, and headaches with structured logging and reporting. Comparable in its approach to patient-led self-tracking and producing shareable reports for clinicians, but broader in scope and not a CE-marked SaMD.
• Click Therapeutics: Prescription digital therapeutics company combining mobile software with pharma partnerships. Comparable in the SaMD-plus-pharma business model and clinical evidence-led approach, and a relevant peer for the anti-CGRP monitoring and research-institution revenue line Migrevention is exploring.

Broad incumbents

• Hinge Health: Large-scale digital musculoskeletal care platform combining app-based exercise therapy with remote clinician coaching. Comparable as a B2B digital pain-care clinic sold to employers and health plans, and as a reference architecture for remote therapeutic monitoring that Migrevention's specialist dashboard parallels.
• Sword Health: Digital MSK and pelvic-health care platform pairing a patient app with virtual specialist oversight. Comparable in the structural model of a digital-first specialty clinic, remote monitoring, and validated clinical outcomes, and a relevant benchmark for Migrevention's chronic pain expansion.
• Akili Interactive: Prescription digital therapeutic company with FDA-cleared software-based treatments. Comparable as a software-based medical device (SaMD) business model with regulatory clearance and prescription/clinical channel distribution, providing a benchmark for the regulatory and commercial path Migrevention is pursuing.
• Big Health: Digital therapeutics company for insomnia and anxiety, sold through employers, payers, and health systems. Comparable as a clinically validated digital therapeutic with enterprise distribution and outcomes-based claims, and a relevant peer for the private insurance and employer channels Migrevention is targeting.
• Omada Health: Virtual-first chronic care platform covering diabetes, hypertension, and musculoskeletal conditions, sold to employers and payers. Comparable in the integrated app-plus-coaching model, the chronic-condition focus, and the employer/payer go-to-market that Migrevention's customer segmentation identifies as a growth lane.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/migrevention
• LinkedInlinkedin.com/company/migrevention

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Migrevention